ArticleInternational ophthalmology2026
Clinical profile and outcomes of endogenous endophthalmitis at the University of the Philippines-Philippine General Hospital: an eight-year retrospective study.
Article in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo describe the clinical profile and outcomes of patients diagnosed with endogenous endophthalmitis at a national university hospital in the Philippines.
methodsThis single-center, 8-year retrospective, cross-sectional chart review examined the medical records of patients clinically diagnosed with endogenous endophthalmitis at the Philippine General Hospital Department of Ophthalmology and Visual Sciences from January 1, 2017 to December 31, 2024. The data included were patient demographics, clinical presentation, initial and final best corrected visual acuity, microbiological profile of intraocular and systemic infections, and management performed.
resultsTwenty-seven eyes of 25 patients were included in the study. The mean age was 50.2 ± 14.7 years old with majority (36%) of the patients in the 51-60 years-old age range. There was a slight male predilection (60%). Twenty-three patients had unilateral disease, while 2 patients had bilateral disease. The mean duration from symptom onset to consult was 10.1 ± 8.8 days and the mean duration of follow-up was 5.4 ± 4.6 months. The most common presenting symptoms were blurred vision (93%), eye redness (85%), and eye pain (70%). The most common presenting signs were vitritis (93%), absence of fundus view and anterior chamber inflammation (85%), and conjunctival injection (74%). Majority of patients (33%) had an initial best corrected visual acuity of hand movement. The most common risk factors identified were diabetes (64%), sepsis (32%), and chronic kidney disease (28%). The culture positivity rate was 44% for both intraocular and systemic cultures. The most common organism isolated from intraocular cultures (vitreous) was Klebsiella pneumoniae and the most common organism isolated from systemic cultures was Staphylococcus aureus, with majority without identified extraocular foci of infection at 48%. Among systemic cultures, Gram-positive organisms were usually seen in the setting of sepsis while Gram-negative organisms were all isolated from the urinary tract. Majority (56%) underwent pars plana vitrectomy as the primary management performed but the final best corrected visual acuity was most commonly no light perception (52%). Only 7% of patients had a final visual acuity better than counting fingers.
conclusionEndogenous endophthalmitis is a severe disease with devastating consequences. Despite timely diagnosis and management, majority of patients still end up with poor nonfunctional vision. Gram-negative microorganisms are the most common etiologic agents of endogenous endophthalmitis consistent with studies in East Asia. However, none of the patient in this study had documented liver pathology.
Indexed as
Identifiers
41886132What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.